Bartel, C <br/><br/>
Remission of a B cell CLL-associated membranoproliferative glomerulonephritis Type I with rituximab and bendamustine.  [electronic resource] 

 -  Clinical nephrology  Apr 2008 
 - 285-9 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>0301-0430 
<br/><br/><label>Standard No.: </label>10.5414/cnp69285  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antineoplastic Agents--therapeutic use<br/>Bendamustine Hydrochloride<br/>Drug Therapy, Combination<br/>Glomerulonephritis, Membranoproliferative--complications<br/>Humans<br/>Immunologic Factors--therapeutic use<br/>Leukemia, Lymphocytic, Chronic, B-Cell--complications<br/>Male<br/>Middle Aged<br/>Nephrotic Syndrome--drug therapy<br/>Nitrogen Mustard Compounds--therapeutic use<br/>Remission Induction<br/>Rituximab